

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.71562268 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.71562268 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.68183327 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.68183327 |
| 5 | pentose-phosphate shunt (GO:0006098) | 4.44556334 |
| 6 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.27881599 |
| 7 | protein localization to endosome (GO:0036010) | 4.15167551 |
| 8 | NADPH regeneration (GO:0006740) | 4.12788960 |
| 9 | galactose catabolic process (GO:0019388) | 4.03813442 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.02562717 |
| 11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.82103457 |
| 12 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.71608658 |
| 13 | lysine metabolic process (GO:0006553) | 3.71493475 |
| 14 | lysine catabolic process (GO:0006554) | 3.71493475 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 3.70204149 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 3.62133896 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 3.52383750 |
| 18 | tricarboxylic acid metabolic process (GO:0072350) | 3.45776477 |
| 19 | mannose metabolic process (GO:0006013) | 3.43239643 |
| 20 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.31893960 |
| 21 | glucose 6-phosphate metabolic process (GO:0051156) | 3.29373531 |
| 22 | GDP-mannose metabolic process (GO:0019673) | 3.28549696 |
| 23 | glucose catabolic process (GO:0006007) | 3.23039146 |
| 24 | valine metabolic process (GO:0006573) | 3.22920854 |
| 25 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.22660142 |
| 26 | protein retention in ER lumen (GO:0006621) | 3.21628691 |
| 27 | 2-oxoglutarate metabolic process (GO:0006103) | 3.20147925 |
| 28 | NADH metabolic process (GO:0006734) | 3.18816258 |
| 29 | regulation of cholesterol homeostasis (GO:2000188) | 3.18391846 |
| 30 | barbed-end actin filament capping (GO:0051016) | 3.18294262 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.16820483 |
| 32 | oxaloacetate metabolic process (GO:0006107) | 3.15285558 |
| 33 | low-density lipoprotein particle clearance (GO:0034383) | 3.13354974 |
| 34 | protein maturation by protein folding (GO:0022417) | 3.08808617 |
| 35 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.08302347 |
| 36 | regulation of early endosome to late endosome transport (GO:2000641) | 3.07566183 |
| 37 | stress fiber assembly (GO:0043149) | 3.07072537 |
| 38 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.03161807 |
| 39 | negative regulation of cell size (GO:0045792) | 3.02735700 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.01327248 |
| 41 | pinocytosis (GO:0006907) | 3.00309793 |
| 42 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.96956604 |
| 43 | modulation by symbiont of host cellular process (GO:0044068) | 2.96498822 |
| 44 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.96042144 |
| 45 | activation of Rac GTPase activity (GO:0032863) | 2.95318772 |
| 46 | positive regulation of nuclease activity (GO:0032075) | 2.95215370 |
| 47 | tricarboxylic acid cycle (GO:0006099) | 2.94009344 |
| 48 | apoptotic process involved in morphogenesis (GO:0060561) | 2.93974057 |
| 49 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.93541368 |
| 50 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.93245795 |
| 51 | response to peptidoglycan (GO:0032494) | 2.90032532 |
| 52 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.89603814 |
| 53 | L-phenylalanine metabolic process (GO:0006558) | 2.89603814 |
| 54 | hexose catabolic process (GO:0019320) | 2.88212510 |
| 55 | glycosphingolipid catabolic process (GO:0046479) | 2.87285388 |
| 56 | maternal placenta development (GO:0001893) | 2.84977406 |
| 57 | 4-hydroxyproline metabolic process (GO:0019471) | 2.81543429 |
| 58 | regulation of cholesterol storage (GO:0010885) | 2.78351322 |
| 59 | modulation by virus of host process (GO:0019054) | 2.76381154 |
| 60 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.76124397 |
| 61 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.74180586 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 2.74105724 |
| 63 | negative regulation of sterol transport (GO:0032372) | 2.74105724 |
| 64 | regulation of extracellular matrix disassembly (GO:0010715) | 2.73288197 |
| 65 | virion assembly (GO:0019068) | 2.72244686 |
| 66 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.72037425 |
| 67 | amyloid precursor protein catabolic process (GO:0042987) | 2.70152834 |
| 68 | regulation of superoxide anion generation (GO:0032928) | 2.68398713 |
| 69 | fatty acid beta-oxidation (GO:0006635) | 2.67511537 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 2.67493744 |
| 71 | cysteine metabolic process (GO:0006534) | 2.67099656 |
| 72 | mitotic nuclear envelope reassembly (GO:0007084) | 2.66461599 |
| 73 | nuclear envelope reassembly (GO:0031468) | 2.66461599 |
| 74 | sexual reproduction (GO:0019953) | 2.66350943 |
| 75 | nucleotide salvage (GO:0043173) | 2.65704572 |
| 76 | regulation of nuclease activity (GO:0032069) | 2.65666663 |
| 77 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.65013995 |
| 78 | adherens junction assembly (GO:0034333) | 2.64072008 |
| 79 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.63475441 |
| 80 | regulation of defense response to virus by virus (GO:0050690) | 2.63276427 |
| 81 | protein autoprocessing (GO:0016540) | 2.63231868 |
| 82 | aspartate family amino acid catabolic process (GO:0009068) | 2.60155378 |
| 83 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.60052681 |
| 84 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.60004721 |
| 85 | glycolipid catabolic process (GO:0019377) | 2.57525940 |
| 86 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57404426 |
| 87 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.57363915 |
| 88 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.57304798 |
| 89 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.56088359 |
| 90 | ethanol oxidation (GO:0006069) | 2.56033036 |
| 91 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.55685555 |
| 92 | activation of MAPKKK activity (GO:0000185) | 2.54599839 |
| 93 | response to laminar fluid shear stress (GO:0034616) | 2.54515313 |
| 94 | apoptotic cell clearance (GO:0043277) | 2.54070937 |
| 95 | positive regulation of pseudopodium assembly (GO:0031274) | 2.53643362 |
| 96 | modulation by symbiont of host defense response (GO:0052031) | 2.53487350 |
| 97 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.53487350 |
| 98 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.53487350 |
| 99 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.53487350 |
| 100 | modulation by symbiont of host immune response (GO:0052553) | 2.53487350 |
| 101 | positive regulation by symbiont of host defense response (GO:0052509) | 2.53487350 |
| 102 | modulation by virus of host morphology or physiology (GO:0019048) | 2.53472065 |
| 103 | cell-substrate adherens junction assembly (GO:0007045) | 2.53391589 |
| 104 | focal adhesion assembly (GO:0048041) | 2.53391589 |
| 105 | beta-amyloid metabolic process (GO:0050435) | 2.53163927 |
| 106 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.52953537 |
| 107 | amino-acid betaine metabolic process (GO:0006577) | 2.52373630 |
| 108 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.52174218 |
| 109 | negative regulation of viral release from host cell (GO:1902187) | 2.51954349 |
| 110 | NADP metabolic process (GO:0006739) | 2.51859311 |
| 111 | pentose metabolic process (GO:0019321) | 2.51820223 |
| 112 | cellular response to virus (GO:0098586) | 2.51814978 |
| 113 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.49892668 |
| 114 | purine nucleotide salvage (GO:0032261) | 2.48442721 |
| 115 | ethanol metabolic process (GO:0006067) | 2.48385799 |
| 116 | glycine metabolic process (GO:0006544) | 2.48069130 |
| 117 | regulation of translational termination (GO:0006449) | 2.47211602 |
| 118 | cellular response to unfolded protein (GO:0034620) | 2.46687437 |
| 119 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.46576713 |
| 120 | regulation of necrotic cell death (GO:0010939) | 2.46376006 |
| 121 | L-phenylalanine catabolic process (GO:0006559) | 2.43952011 |
| 122 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.43952011 |
| 123 | UV protection (GO:0009650) | 2.43812928 |
| 124 | cellular response to topologically incorrect protein (GO:0035967) | 2.43340771 |
| 125 | carnitine metabolic process (GO:0009437) | 2.42977683 |
| 126 | fatty acid oxidation (GO:0019395) | 2.42859503 |
| 127 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.42726757 |
| 128 | glyoxylate metabolic process (GO:0046487) | 2.42537750 |
| 129 | vesicle coating (GO:0006901) | 2.39986321 |
| 130 | protein insertion into membrane (GO:0051205) | 2.39856967 |
| 131 | cellular modified amino acid catabolic process (GO:0042219) | 2.39800266 |
| 132 | proline biosynthetic process (GO:0006561) | 2.39705955 |
| 133 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.39666389 |
| 134 | sequestering of actin monomers (GO:0042989) | 2.39374663 |
| 135 | fatty acid catabolic process (GO:0009062) | 2.38913234 |
| 136 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.38880322 |
| 137 | cellular ketone body metabolic process (GO:0046950) | 2.38534962 |
| 138 | ER-nucleus signaling pathway (GO:0006984) | 2.38112867 |
| 139 | regulation of fatty acid oxidation (GO:0046320) | 2.37896491 |
| 140 | negative regulation of innate immune response (GO:0045824) | 2.37327103 |
| 141 | lipid oxidation (GO:0034440) | 2.36596268 |
| 142 | primary alcohol catabolic process (GO:0034310) | 2.35624755 |
| 143 | viral protein processing (GO:0019082) | 2.34822801 |
| 144 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.34614536 |
| 145 | negative regulation of lipid transport (GO:0032369) | 2.34555875 |
| 146 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.34422454 |
| 147 | regulation of translational fidelity (GO:0006450) | 2.33886389 |
| 148 | nucleoside salvage (GO:0043174) | 2.33720698 |
| 149 | kynurenine metabolic process (GO:0070189) | 2.33210221 |
| 150 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.33184475 |
| 151 | skin morphogenesis (GO:0043589) | 2.32890428 |
| 152 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.32353877 |
| 153 | negative regulation of cell killing (GO:0031342) | 2.32075325 |
| 154 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.32075325 |
| 155 | positive regulation of lamellipodium assembly (GO:0010592) | 2.32032488 |
| 156 | amino sugar catabolic process (GO:0046348) | 2.31463452 |
| 157 | regulation of response to interferon-gamma (GO:0060330) | 2.31313249 |
| 158 | epithelial cell-cell adhesion (GO:0090136) | 2.30219868 |
| 159 | regulation of viral release from host cell (GO:1902186) | 2.29028097 |
| 160 | regulation of triglyceride catabolic process (GO:0010896) | 2.28988164 |
| 161 | fructose metabolic process (GO:0006000) | 2.28779130 |
| 162 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.28762718 |
| 163 | pyrimidine nucleoside salvage (GO:0043097) | 2.28762150 |
| 164 | pyrimidine-containing compound salvage (GO:0008655) | 2.28762150 |
| 165 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.28753417 |
| 166 | regulation of leukocyte degranulation (GO:0043300) | 2.28482624 |
| 167 | regulation of podosome assembly (GO:0071801) | 2.26904213 |
| 168 | negative regulation of necroptotic process (GO:0060546) | 2.26858612 |
| 169 | cell-cell junction maintenance (GO:0045217) | 2.26550477 |
| 170 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.26151647 |
| 171 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.24768302 |
| 172 | response to progesterone (GO:0032570) | 2.23612607 |
| 173 | mitochondrial fusion (GO:0008053) | 2.23084790 |
| 174 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.22962323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.68817310 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.59567592 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.11820008 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.85752410 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.61441259 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43485861 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.14213225 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.12713081 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.12236794 |
| 10 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.07605184 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.04502512 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.93730404 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91421220 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89139072 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85111241 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83103331 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81092323 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78160008 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72192513 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58601754 |
| 21 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.56506972 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56018094 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.55860773 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.54187272 |
| 25 | ATF3_27146783_Chip-Seq_COLON_Human | 1.53052293 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51082750 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50665687 |
| 28 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47947795 |
| 29 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47262883 |
| 30 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.44308955 |
| 31 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.41870353 |
| 32 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41199216 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.39788881 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38303232 |
| 35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37483233 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.35744476 |
| 37 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.35309106 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34988424 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34187845 |
| 40 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.33720445 |
| 41 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33665699 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33148379 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31392651 |
| 44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.31324589 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30461712 |
| 46 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29622437 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29161964 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.29095397 |
| 49 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.28154478 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27592627 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26711062 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26616343 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26065134 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25222149 |
| 55 | P68_20966046_ChIP-Seq_HELA_Human | 1.25217591 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23862827 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23761592 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23596599 |
| 59 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22232856 |
| 60 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21926605 |
| 61 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20915503 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20670471 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20584764 |
| 64 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19404356 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19131051 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18436555 |
| 67 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.18429488 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17316319 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16936898 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15441651 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14803112 |
| 72 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.14599609 |
| 73 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13889841 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.13407122 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13281565 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12356539 |
| 77 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.12341375 |
| 78 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12194301 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12125994 |
| 80 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12016304 |
| 81 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11856184 |
| 82 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11825044 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11736587 |
| 84 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11016755 |
| 85 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.10743877 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10723730 |
| 87 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10606105 |
| 88 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10522818 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10502530 |
| 90 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.10238900 |
| 91 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10093477 |
| 92 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.09896355 |
| 93 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09738949 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09486034 |
| 95 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06421271 |
| 96 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06384228 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06179144 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06107753 |
| 99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05755393 |
| 100 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05442089 |
| 101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04737921 |
| 102 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04425437 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.03611140 |
| 104 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03186493 |
| 105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03127429 |
| 106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03024904 |
| 107 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02195342 |
| 108 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01743201 |
| 109 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01531611 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00778728 |
| 111 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00474648 |
| 112 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99733133 |
| 113 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99712145 |
| 114 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.99696557 |
| 115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99668026 |
| 116 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99526050 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99387581 |
| 118 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99099509 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98551284 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98255379 |
| 121 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97775977 |
| 122 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97675869 |
| 123 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97077018 |
| 124 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.96934929 |
| 125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96768406 |
| 126 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.96485127 |
| 127 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96368809 |
| 128 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95919122 |
| 129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95248032 |
| 130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95106319 |
| 131 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93342171 |
| 132 | P300_27268052_Chip-Seq_Bcells_Human | 0.93333233 |
| 133 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.92925385 |
| 134 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91964124 |
| 135 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91479465 |
| 136 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.91442140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 3.68448209 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.63480324 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.37911331 |
| 4 | MP0005360_urolithiasis | 3.37120401 |
| 5 | MP0005451_abnormal_body_composition | 3.21279255 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.05880943 |
| 7 | MP0008260_abnormal_autophagy | 2.85881721 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.80824836 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.78171616 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.50284959 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.48835640 |
| 12 | MP0005365_abnormal_bile_salt | 2.39342377 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.30711612 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.20659047 |
| 15 | MP0009278_abnormal_bone_marrow | 2.02969630 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 1.95150106 |
| 17 | MP0010329_abnormal_lipoprotein_level | 1.90859284 |
| 18 | MP0005083_abnormal_biliary_tract | 1.82945206 |
| 19 | MP0001666_abnormal_nutrient_absorption | 1.80694123 |
| 20 | MP0001849_ear_inflammation | 1.71561737 |
| 21 | MP0000604_amyloidosis | 1.69883141 |
| 22 | MP0003436_decreased_susceptibility_to | 1.67797924 |
| 23 | MP0005257_abnormal_intraocular_pressure | 1.62073121 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.61690197 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.59693613 |
| 26 | MP0004947_skin_inflammation | 1.59059480 |
| 27 | MP0000678_abnormal_parathyroid_gland | 1.57775931 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.57705146 |
| 29 | MP0004510_myositis | 1.52523584 |
| 30 | MP0003252_abnormal_bile_duct | 1.52386225 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.49904164 |
| 32 | MP0000609_abnormal_liver_physiology | 1.49855254 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.47751168 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.47464736 |
| 35 | MP0006054_spinal_hemorrhage | 1.47255301 |
| 36 | MP0003303_peritoneal_inflammation | 1.46930135 |
| 37 | MP0000685_abnormal_immune_system | 1.43547216 |
| 38 | MP0003866_abnormal_defecation | 1.41489943 |
| 39 | MP0003329_amyloid_beta_deposits | 1.41200821 |
| 40 | MP0005332_abnormal_amino_acid | 1.40684330 |
| 41 | MP0002796_impaired_skin_barrier | 1.34434776 |
| 42 | MP0005275_abnormal_skin_tensile | 1.32884498 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.31723456 |
| 44 | MP0005023_abnormal_wound_healing | 1.31428080 |
| 45 | MP0003091_abnormal_cell_migration | 1.27753268 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.27149617 |
| 47 | MP0001756_abnormal_urination | 1.27038609 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.25808292 |
| 49 | MP0004264_abnormal_extraembryonic_tissu | 1.25372289 |
| 50 | MP0005409_darkened_coat_color | 1.25043640 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.24519694 |
| 52 | MP0004858_abnormal_nervous_system | 1.24345927 |
| 53 | MP0004130_abnormal_muscle_cell | 1.18248518 |
| 54 | MP0003724_increased_susceptibility_to | 1.16949730 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.15673517 |
| 56 | MP0004233_abnormal_muscle_weight | 1.14847503 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.10586986 |
| 58 | MP0001873_stomach_inflammation | 1.09593936 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.09180333 |
| 60 | MP0000598_abnormal_liver_morphology | 1.07768402 |
| 61 | MP0006082_CNS_inflammation | 1.07585056 |
| 62 | MP0009785_altered_susceptibility_to | 1.05041133 |
| 63 | MP0000858_altered_metastatic_potential | 1.04874435 |
| 64 | MP0001348_abnormal_lacrimal_gland | 1.04779568 |
| 65 | MP0002909_abnormal_adrenal_gland | 1.03785945 |
| 66 | MP0005501_abnormal_skin_physiology | 1.02669091 |
| 67 | MP0000358_abnormal_cell_content/ | 1.01775866 |
| 68 | MP0000490_abnormal_crypts_of | 1.00152557 |
| 69 | MP0002098_abnormal_vibrissa_morphology | 1.00014868 |
| 70 | MP0005025_abnormal_response_to | 0.99648719 |
| 71 | MP0002166_altered_tumor_susceptibility | 0.99577972 |
| 72 | MP0002089_abnormal_postnatal_growth/wei | 0.99474392 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 0.99149279 |
| 74 | MP0008469_abnormal_protein_level | 0.98267012 |
| 75 | MP0002723_abnormal_immune_serum | 0.98107453 |
| 76 | MP0001845_abnormal_inflammatory_respons | 0.96524779 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.96098917 |
| 78 | MP0000477_abnormal_intestine_morphology | 0.95925174 |
| 79 | MP0003186_abnormal_redox_activity | 0.94742246 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.94712436 |
| 81 | MP0005387_immune_system_phenotype | 0.94276921 |
| 82 | MP0001790_abnormal_immune_system | 0.94276921 |
| 83 | MP0001533_abnormal_skeleton_physiology | 0.93047857 |
| 84 | MP0005390_skeleton_phenotype | 0.93012057 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.92823544 |
| 86 | MP0003279_aneurysm | 0.91538479 |
| 87 | MP0001853_heart_inflammation | 0.91166677 |
| 88 | MP0001835_abnormal_antigen_presentation | 0.90646482 |
| 89 | MP0005375_adipose_tissue_phenotype | 0.90428140 |
| 90 | MP0009931_abnormal_skin_appearance | 0.88138470 |
| 91 | MP0005166_decreased_susceptibility_to | 0.87863696 |
| 92 | MP0005165_increased_susceptibility_to | 0.87137884 |
| 93 | MP0003075_altered_response_to | 0.87033288 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.86841556 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.86319917 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.85992264 |
| 97 | MP0008874_decreased_physiological_sensi | 0.85351356 |
| 98 | MP0000343_altered_response_to | 0.84537663 |
| 99 | MP0000750_abnormal_muscle_regeneration | 0.84189936 |
| 100 | MP0002254_reproductive_system_inflammat | 0.84168910 |
| 101 | MP0008961_abnormal_basal_metabolism | 0.84049106 |
| 102 | MP0003763_abnormal_thymus_physiology | 0.83704465 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.83009537 |
| 104 | MP0010307_abnormal_tumor_latency | 0.82341097 |
| 105 | MP0002060_abnormal_skin_morphology | 0.81604885 |
| 106 | MP0000537_abnormal_urethra_morphology | 0.80554802 |
| 107 | MP0000013_abnormal_adipose_tissue | 0.80417940 |
| 108 | MP0001545_abnormal_hematopoietic_system | 0.80226063 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.80226063 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.79955042 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.79336786 |
| 112 | MP0003453_abnormal_keratinocyte_physiol | 0.79265269 |
| 113 | MP0000681_abnormal_thyroid_gland | 0.79259091 |
| 114 | MP0000467_abnormal_esophagus_morphology | 0.78046729 |
| 115 | MP0000716_abnormal_immune_system | 0.77413852 |
| 116 | MP0001243_abnormal_dermal_layer | 0.77325773 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.77255315 |
| 118 | MP0002429_abnormal_blood_cell | 0.76826308 |
| 119 | MP0002269_muscular_atrophy | 0.76730171 |
| 120 | MP0001958_emphysema | 0.75887997 |
| 121 | MP0002653_abnormal_ependyma_morphology | 0.75360194 |
| 122 | MP0003448_altered_tumor_morphology | 0.74928821 |
| 123 | MP0000751_myopathy | 0.74668471 |
| 124 | MP0003123_paternal_imprinting | 0.73960806 |
| 125 | MP0003795_abnormal_bone_structure | 0.73720079 |
| 126 | MP0002452_abnormal_antigen_presenting | 0.73690599 |
| 127 | MP0005621_abnormal_cell_physiology | 0.73605023 |
| 128 | MP0002405_respiratory_system_inflammati | 0.73269672 |
| 129 | MP0002419_abnormal_innate_immunity | 0.73077648 |
| 130 | MP0001819_abnormal_immune_cell | 0.72716812 |
| 131 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72244468 |
| 132 | MP0002420_abnormal_adaptive_immunity | 0.71857312 |
| 133 | MP0001730_embryonic_growth_arrest | 0.71349453 |
| 134 | MP0001800_abnormal_humoral_immune | 0.70746315 |
| 135 | MP0001216_abnormal_epidermal_layer | 0.70490654 |
| 136 | MP0005000_abnormal_immune_tolerance | 0.70247468 |
| 137 | MP0004185_abnormal_adipocyte_glucose | 0.69615707 |
| 138 | MP0009642_abnormal_blood_homeostasis | 0.69413372 |
| 139 | MP0000747_muscle_weakness | 0.69208762 |
| 140 | MP0002877_abnormal_melanocyte_morpholog | 0.68924411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.11036515 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.11036515 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 3.11036515 |
| 4 | Premature rupture of membranes (HP:0001788) | 3.02390995 |
| 5 | Hyperacusis (HP:0010780) | 2.95094420 |
| 6 | Eczematoid dermatitis (HP:0000976) | 2.91380235 |
| 7 | Xanthomatosis (HP:0000991) | 2.90493311 |
| 8 | Distal lower limb muscle weakness (HP:0009053) | 2.89152719 |
| 9 | Hand muscle atrophy (HP:0009130) | 2.85794699 |
| 10 | Hyperammonemia (HP:0001987) | 2.80749944 |
| 11 | Distal lower limb amyotrophy (HP:0008944) | 2.77114295 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.73060023 |
| 13 | Cholecystitis (HP:0001082) | 2.69155835 |
| 14 | Abnormal gallbladder physiology (HP:0012438) | 2.69155835 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.67744834 |
| 16 | Late onset (HP:0003584) | 2.67405057 |
| 17 | Abnormality of macrophages (HP:0004311) | 2.63987387 |
| 18 | Distal upper limb amyotrophy (HP:0007149) | 2.62239327 |
| 19 | Upper limb amyotrophy (HP:0009129) | 2.62239327 |
| 20 | Dysostosis multiplex (HP:0000943) | 2.60840624 |
| 21 | Multiple enchondromatosis (HP:0005701) | 2.59037531 |
| 22 | Loss of speech (HP:0002371) | 2.56697218 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 2.54839862 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 2.54813492 |
| 25 | Deep venous thrombosis (HP:0002625) | 2.53421993 |
| 26 | Axonal loss (HP:0003447) | 2.52026977 |
| 27 | Mucopolysacchariduria (HP:0008155) | 2.51639769 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51639769 |
| 29 | Ketosis (HP:0001946) | 2.51220835 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.49827291 |
| 31 | J-shaped sella turcica (HP:0002680) | 2.49660085 |
| 32 | Ketoacidosis (HP:0001993) | 2.44156051 |
| 33 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.43964355 |
| 34 | Hypobetalipoproteinemia (HP:0003563) | 2.41311861 |
| 35 | Hyperparathyroidism (HP:0000843) | 2.37983626 |
| 36 | Myoglobinuria (HP:0002913) | 2.36585996 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.36576757 |
| 38 | Asymmetric septal hypertrophy (HP:0001670) | 2.36457270 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.35723689 |
| 40 | Long palpebral fissure (HP:0000637) | 2.34474860 |
| 41 | Hemorrhage of the eye (HP:0011885) | 2.34205926 |
| 42 | Abnormal cartilage morphology (HP:0002763) | 2.33687831 |
| 43 | Neuronal loss in central nervous system (HP:0002529) | 2.33601848 |
| 44 | Nasal polyposis (HP:0100582) | 2.31908022 |
| 45 | Myopathic facies (HP:0002058) | 2.31413615 |
| 46 | Gout (HP:0001997) | 2.30739470 |
| 47 | Abnormality of the nasal mucosa (HP:0000433) | 2.30542684 |
| 48 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.27718618 |
| 49 | Hypoglycemic coma (HP:0001325) | 2.26491260 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25607472 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25607472 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25607472 |
| 53 | Conjunctival hamartoma (HP:0100780) | 2.24296452 |
| 54 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.23809714 |
| 55 | Nonimmune hydrops fetalis (HP:0001790) | 2.23206081 |
| 56 | Hypertensive crisis (HP:0100735) | 2.21374904 |
| 57 | Cellulitis (HP:0100658) | 2.19765727 |
| 58 | Rhabdomyolysis (HP:0003201) | 2.19405668 |
| 59 | Short nail (HP:0001799) | 2.18374191 |
| 60 | Cervical subluxation (HP:0003308) | 2.16610058 |
| 61 | Complement deficiency (HP:0004431) | 2.15521015 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.14152285 |
| 63 | Abnormality of proline metabolism (HP:0010907) | 2.12825029 |
| 64 | Hydroxyprolinuria (HP:0003080) | 2.12825029 |
| 65 | Hyperglycinuria (HP:0003108) | 2.12218033 |
| 66 | Polygenic inheritance (HP:0010982) | 2.11681582 |
| 67 | Flat acetabular roof (HP:0003180) | 2.05758907 |
| 68 | Rough bone trabeculation (HP:0100670) | 2.05592932 |
| 69 | Protrusio acetabuli (HP:0003179) | 2.05019964 |
| 70 | Abnormality of the Achilles tendon (HP:0005109) | 2.04732611 |
| 71 | Malnutrition (HP:0004395) | 2.04285539 |
| 72 | Limb-girdle muscle atrophy (HP:0003797) | 2.03447141 |
| 73 | Cerebral aneurysm (HP:0004944) | 2.03131352 |
| 74 | Insomnia (HP:0100785) | 2.02890385 |
| 75 | Amyloidosis (HP:0011034) | 2.01889079 |
| 76 | Abnormality of complement system (HP:0005339) | 2.00955819 |
| 77 | Abnormality of glycine metabolism (HP:0010895) | 2.00856818 |
| 78 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.00856818 |
| 79 | Cerebral inclusion bodies (HP:0100314) | 2.00851960 |
| 80 | Gastrointestinal dysmotility (HP:0002579) | 1.99612044 |
| 81 | Spastic diplegia (HP:0001264) | 1.98037941 |
| 82 | Broad face (HP:0000283) | 1.97909570 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 1.97756466 |
| 84 | Ulnar bowing (HP:0003031) | 1.97395326 |
| 85 | Hypolipoproteinemia (HP:0010981) | 1.96717906 |
| 86 | Purpura (HP:0000979) | 1.96522013 |
| 87 | Intrahepatic cholestasis (HP:0001406) | 1.95644006 |
| 88 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.94875409 |
| 89 | Stridor (HP:0010307) | 1.94514401 |
| 90 | Achilles tendon contracture (HP:0001771) | 1.93537566 |
| 91 | Nuclear cataract (HP:0100018) | 1.93408873 |
| 92 | Pustule (HP:0200039) | 1.92724916 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92656927 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 1.92656927 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92471822 |
| 96 | Petechiae (HP:0000967) | 1.92319202 |
| 97 | Neurofibrillary tangles (HP:0002185) | 1.92048145 |
| 98 | Difficulty climbing stairs (HP:0003551) | 1.91499197 |
| 99 | Supranuclear gaze palsy (HP:0000605) | 1.89785874 |
| 100 | Recurrent abscess formation (HP:0002722) | 1.89558120 |
| 101 | Mesangial abnormality (HP:0001966) | 1.89104170 |
| 102 | Neonatal onset (HP:0003623) | 1.89084485 |
| 103 | Generalized aminoaciduria (HP:0002909) | 1.88990659 |
| 104 | Increased IgE level (HP:0003212) | 1.87947578 |
| 105 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.87899996 |
| 106 | Bone pain (HP:0002653) | 1.87719152 |
| 107 | Abnormality of the lower motor neuron (HP:0002366) | 1.87104641 |
| 108 | Apathy (HP:0000741) | 1.87051340 |
| 109 | Growth hormone excess (HP:0000845) | 1.86821117 |
| 110 | Flattened epiphyses (HP:0003071) | 1.85887766 |
| 111 | Long toe (HP:0010511) | 1.85470330 |
| 112 | Frequent falls (HP:0002359) | 1.85200482 |
| 113 | Chronic obstructive pulmonary disease (HP:0006510) | 1.84963252 |
| 114 | Obstructive lung disease (HP:0006536) | 1.84963252 |
| 115 | Increased serum ferritin (HP:0003281) | 1.84881457 |
| 116 | Prolonged neonatal jaundice (HP:0006579) | 1.84793903 |
| 117 | Ulnar deviation of the wrist (HP:0003049) | 1.84533328 |
| 118 | Diminished motivation (HP:0000745) | 1.83963125 |
| 119 | Hepatosplenomegaly (HP:0001433) | 1.83745726 |
| 120 | Palpitations (HP:0001962) | 1.82792407 |
| 121 | Trismus (HP:0000211) | 1.81746712 |
| 122 | Spinal rigidity (HP:0003306) | 1.81584630 |
| 123 | Reticulocytosis (HP:0001923) | 1.81524229 |
| 124 | Abnormality of the thoracic spine (HP:0100711) | 1.81204835 |
| 125 | Global brain atrophy (HP:0002283) | 1.80669342 |
| 126 | Mitral regurgitation (HP:0001653) | 1.76943543 |
| 127 | Polycythemia (HP:0001901) | 1.76442931 |
| 128 | Abnormality of purine metabolism (HP:0004352) | 1.75597168 |
| 129 | Thoracic kyphosis (HP:0002942) | 1.75349917 |
| 130 | Vertebral compression fractures (HP:0002953) | 1.74855370 |
| 131 | Hyperlipoproteinemia (HP:0010980) | 1.74495311 |
| 132 | Generalized amyotrophy (HP:0003700) | 1.74087388 |
| 133 | Fragile skin (HP:0001030) | 1.73707947 |
| 134 | Increased connective tissue (HP:0009025) | 1.73453846 |
| 135 | Protuberant abdomen (HP:0001538) | 1.72948799 |
| 136 | Hyperglycinemia (HP:0002154) | 1.72622657 |
| 137 | Back pain (HP:0003418) | 1.72486707 |
| 138 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.72330863 |
| 139 | Lower limb amyotrophy (HP:0007210) | 1.72322897 |
| 140 | Bulbar palsy (HP:0001283) | 1.72073774 |
| 141 | Progressive neurologic deterioration (HP:0002344) | 1.71323176 |
| 142 | Cholelithiasis (HP:0001081) | 1.70947749 |
| 143 | Abnormal neuron morphology (HP:0012757) | 1.70361162 |
| 144 | Abnormality of the motor neurons (HP:0002450) | 1.70361162 |
| 145 | Hypoalphalipoproteinemia (HP:0003233) | 1.70169238 |
| 146 | Increased variability in muscle fiber diameter (HP:0003557) | 1.69791396 |
| 147 | Facial diplegia (HP:0001349) | 1.69231039 |
| 148 | Abnormal trabecular bone morphology (HP:0100671) | 1.69122280 |
| 149 | Upper motor neuron abnormality (HP:0002127) | 1.69012688 |
| 150 | Broad distal phalanx of finger (HP:0009836) | 1.68944897 |
| 151 | Blue sclerae (HP:0000592) | 1.68494654 |
| 152 | Peritonitis (HP:0002586) | 1.68447617 |
| 153 | Hypertriglyceridemia (HP:0002155) | 1.68223522 |
| 154 | Metaphyseal cupping (HP:0003021) | 1.67821671 |
| 155 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.67119025 |
| 156 | Recurrent bacterial skin infections (HP:0005406) | 1.66851421 |
| 157 | Progressive muscle weakness (HP:0003323) | 1.66671635 |
| 158 | Ileus (HP:0002595) | 1.66155843 |
| 159 | Diaphragmatic weakness (HP:0009113) | 1.65753713 |
| 160 | Thrombocytosis (HP:0001894) | 1.65557640 |
| 161 | Angiofibromas (HP:0010615) | 1.64539964 |
| 162 | Adenoma sebaceum (HP:0009720) | 1.64539964 |
| 163 | Cardiomegaly (HP:0001640) | 1.64538615 |
| 164 | Thin bony cortex (HP:0002753) | 1.64345695 |
| 165 | Abdominal distention (HP:0003270) | 1.64165594 |
| 166 | Papilloma (HP:0012740) | 1.61810047 |
| 167 | Verrucae (HP:0200043) | 1.61810047 |
| 168 | Ragged-red muscle fibers (HP:0003200) | 1.61610417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.63514423 |
| 2 | ERN1 | 3.75929280 |
| 3 | PKN2 | 3.75040176 |
| 4 | SMG1 | 3.05950118 |
| 5 | TESK1 | 3.02360563 |
| 6 | IRAK3 | 2.92934691 |
| 7 | PRPF4B | 2.65632478 |
| 8 | EEF2K | 2.58063364 |
| 9 | BCKDK | 2.35101296 |
| 10 | LRRK2 | 2.30666659 |
| 11 | TESK2 | 2.21457476 |
| 12 | SCYL2 | 2.15906572 |
| 13 | LMTK2 | 2.03349809 |
| 14 | TTN | 2.01396012 |
| 15 | FGFR4 | 1.97844165 |
| 16 | TAOK2 | 1.97186634 |
| 17 | MAP4K1 | 1.86269177 |
| 18 | MAPKAPK3 | 1.74401858 |
| 19 | BLK | 1.70479756 |
| 20 | KSR2 | 1.66906731 |
| 21 | EPHA2 | 1.65227425 |
| 22 | NEK1 | 1.63157541 |
| 23 | ZAP70 | 1.52741619 |
| 24 | PTK6 | 1.49787106 |
| 25 | FLT3 | 1.47648151 |
| 26 | STK10 | 1.44365911 |
| 27 | TBK1 | 1.40343361 |
| 28 | PAK4 | 1.39189360 |
| 29 | TYK2 | 1.39113774 |
| 30 | MAP2K3 | 1.36639663 |
| 31 | MAP3K11 | 1.35597449 |
| 32 | LIMK1 | 1.33588569 |
| 33 | PDGFRA | 1.26769417 |
| 34 | GRK6 | 1.26069333 |
| 35 | MAP3K10 | 1.23640613 |
| 36 | MST1R | 1.22924980 |
| 37 | TAOK1 | 1.21693769 |
| 38 | MAP2K2 | 1.13152770 |
| 39 | KDR | 1.11621233 |
| 40 | SIK1 | 1.10057968 |
| 41 | IRAK4 | 1.03124347 |
| 42 | MAP3K3 | 1.02666886 |
| 43 | RIPK4 | 1.02317803 |
| 44 | MAP2K1 | 1.01507360 |
| 45 | RIPK1 | 1.01054472 |
| 46 | PDK3 | 0.99738002 |
| 47 | PDK4 | 0.99738002 |
| 48 | SIK3 | 0.98865579 |
| 49 | PTK2 | 0.97637362 |
| 50 | DAPK3 | 0.97179375 |
| 51 | DAPK2 | 0.95865962 |
| 52 | MAP3K8 | 0.95088338 |
| 53 | BUB1 | 0.89790817 |
| 54 | JAK3 | 0.89702130 |
| 55 | ILK | 0.87415691 |
| 56 | PRKD2 | 0.86653758 |
| 57 | PIM2 | 0.85929769 |
| 58 | MAP3K2 | 0.84505830 |
| 59 | MATK | 0.83479313 |
| 60 | VRK2 | 0.82754414 |
| 61 | NME2 | 0.82360223 |
| 62 | BMX | 0.82233551 |
| 63 | CDK12 | 0.81463667 |
| 64 | RPS6KB2 | 0.80454444 |
| 65 | RET | 0.79479457 |
| 66 | RPS6KA4 | 0.79249434 |
| 67 | DDR2 | 0.78433689 |
| 68 | MAP2K6 | 0.77376163 |
| 69 | BRAF | 0.77186152 |
| 70 | CDC42BPA | 0.76097861 |
| 71 | PRKG2 | 0.75907095 |
| 72 | PDPK1 | 0.75893226 |
| 73 | CAMKK1 | 0.74330506 |
| 74 | MOS | 0.73851796 |
| 75 | EPHB1 | 0.73012169 |
| 76 | ABL2 | 0.72932320 |
| 77 | MAP3K14 | 0.72327143 |
| 78 | MAP3K13 | 0.72317950 |
| 79 | MAP3K1 | 0.71908639 |
| 80 | PASK | 0.71485206 |
| 81 | ARAF | 0.70809985 |
| 82 | TGFBR1 | 0.70146665 |
| 83 | MYLK | 0.68380376 |
| 84 | JAK1 | 0.68178087 |
| 85 | IRAK2 | 0.67284839 |
| 86 | DAPK1 | 0.67023156 |
| 87 | MAP3K6 | 0.66553398 |
| 88 | MAPK11 | 0.63878040 |
| 89 | JAK2 | 0.63511040 |
| 90 | TGFBR2 | 0.63508126 |
| 91 | ITK | 0.63309371 |
| 92 | ICK | 0.63033703 |
| 93 | DYRK1B | 0.63010406 |
| 94 | PRKD3 | 0.62575501 |
| 95 | EPHA3 | 0.62361384 |
| 96 | BTK | 0.61898988 |
| 97 | NEK9 | 0.61034133 |
| 98 | MARK2 | 0.60349700 |
| 99 | CDK7 | 0.60075471 |
| 100 | MAP3K9 | 0.59628582 |
| 101 | FER | 0.56713355 |
| 102 | FGR | 0.55696946 |
| 103 | SIK2 | 0.55448497 |
| 104 | RPS6KL1 | 0.55419754 |
| 105 | RPS6KC1 | 0.55419754 |
| 106 | ALK | 0.51400031 |
| 107 | HIPK2 | 0.50765353 |
| 108 | EPHB2 | 0.49329160 |
| 109 | AURKA | 0.46260935 |
| 110 | PIK3CG | 0.45122370 |
| 111 | MET | 0.44915303 |
| 112 | PAK1 | 0.44190966 |
| 113 | MAPKAPK2 | 0.44057093 |
| 114 | KIT | 0.44014084 |
| 115 | RPS6KA2 | 0.43813031 |
| 116 | TYRO3 | 0.43579119 |
| 117 | PAK3 | 0.43480557 |
| 118 | SYK | 0.41266743 |
| 119 | NTRK1 | 0.40852478 |
| 120 | PRKCI | 0.40332751 |
| 121 | ACVR1B | 0.39250571 |
| 122 | PAK2 | 0.38864010 |
| 123 | MAP3K7 | 0.38737027 |
| 124 | CSF1R | 0.36840195 |
| 125 | STK38 | 0.35284668 |
| 126 | RAF1 | 0.35002673 |
| 127 | PDK1 | 0.33782105 |
| 128 | CDK11A | 0.33088682 |
| 129 | TNK2 | 0.32794895 |
| 130 | CDK14 | 0.32775624 |
| 131 | CSK | 0.32042643 |
| 132 | MTOR | 0.30406937 |
| 133 | LATS2 | 0.30389970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.24110414 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.17690362 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53473345 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.52515705 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.47051783 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.31585624 |
| 7 | Carbon metabolism_Homo sapiens_hsa01200 | 2.23051235 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.12532955 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02183117 |
| 10 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.00580575 |
| 11 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.98053535 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.88895123 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.80341632 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.75051465 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.71249708 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.65524229 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.62945811 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.61594486 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.61179131 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.58761723 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57490779 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56608098 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.56433886 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56257477 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52985861 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49393335 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47900164 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.47175585 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.47064157 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44484913 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43330815 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41802978 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40731970 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.40544678 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36285632 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.34950432 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.34694514 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.31705529 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.31216768 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24736369 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22214920 |
| 42 | Bladder cancer_Homo sapiens_hsa05219 | 1.17775607 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.15201313 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12951296 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09928330 |
| 46 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.09200219 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06719592 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.05448694 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.05447974 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.03815222 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.02083879 |
| 52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00242539 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.00153291 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99934459 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99911823 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99622547 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.98410331 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98193062 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97159199 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.97078434 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95235092 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95028071 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94399769 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.93749692 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91743041 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.90843572 |
| 67 | Proteasome_Homo sapiens_hsa03050 | 0.90840958 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89640450 |
| 69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89627933 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88752795 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87683767 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87608651 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85970627 |
| 74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85561500 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.84799331 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80979179 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79496461 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78890833 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77323841 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76729478 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76290119 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75518232 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.74634764 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.74219746 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74141736 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73178682 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72151461 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71835606 |
| 89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69849615 |
| 90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69252588 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69071360 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68547390 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.67978472 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.67736881 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67158555 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66537982 |
| 97 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65244543 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64459910 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64439051 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63785989 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62571770 |
| 102 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60362308 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59886420 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59631784 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58703561 |
| 106 | Leishmaniasis_Homo sapiens_hsa05140 | 0.58031040 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57777737 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.57727663 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57628586 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.56803223 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.56723856 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56357437 |
| 113 | Malaria_Homo sapiens_hsa05144 | 0.56094238 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55956901 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55848758 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54313673 |
| 117 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54235448 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.53572042 |
| 119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52284526 |
| 120 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52128535 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51937351 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51688452 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50995004 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50618721 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49766766 |
| 126 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48471984 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48277965 |
| 128 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.47467159 |
| 129 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47177908 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46962887 |
| 131 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46608997 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44877695 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44804694 |
| 134 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42766692 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42050680 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41978543 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41390927 |
| 138 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40273158 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.40061233 |
| 140 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39379914 |
| 141 | Tuberculosis_Homo sapiens_hsa05152 | 0.39217293 |
| 142 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38507880 |
| 143 | ABC transporters_Homo sapiens_hsa02010 | 0.37351029 |
| 144 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36850131 |
| 145 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36745149 |
| 146 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36349256 |
| 147 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36118645 |
| 148 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34544670 |

